Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.solvay.com | |
Market Cap | 434.68 Cr. | |
Enterprise Value(EV) | 512.23 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 21.61 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 27.36 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 25.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 83.70 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 7.06 | Calculated using Price: 591.15 |
Dividend Yield | 0.34 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.74 Cr. | 7,353,060 Shares |
FaceValue | 10 | |
Company Profile | ||
Sunshield Chemicals Ltd., (SCL) was incorporated in 1986, as private limited company and then became public. Satish Kelkar, the managing director, along with his close friends and relatives, started the business. This family business was later turned into a listed company and in April 2005, Amit C Choksey, from the family of founder promoters of Asian Paints, and Chairman of Mazda Colours, a prime Pthalocyanine blue & green manufacturer co- promoted Sunshield's business in the field of Antioxidants and specialities for prime global customers. |
1 Day |
|
+1.99% |
1 Week |
|
-3.17% |
1 Month |
|
+8.63% |
3 Month |
|
-3.70% |
6 Month |
|
+18.96% |
1 Year |
|
+36.99% |
2 Year |
|
+195.99% |
5 Year |
|
+82.74% |
10 Year |
|
+896.21% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -1.90 | -16.45 | -4.91 | -50.08 | 11.51 | 1.99 | 5.57 | 74.72 | 68.85 | |
Return on Capital Employed (%) | 12.57 | -0.50 | 6.99 | 1.22 | 9.72 | 9.17 | 9.40 | 20.41 | 35.72 | |
Return on Assets (%) | -0.45 | -2.75 | -0.60 | -4.55 | 0.80 | 0.14 | 0.43 | 9.74 | 16.80 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 21 | 18 | 17 | 10 | 11 | 11 | 12 | 26 | 54 | 62 | |
Non Curr. Liab. | 28 | 48 | 63 | 49 | 47 | 22 | 53 | 53 | 49 | 42 | |
Curr. Liab. | 51 | 66 | 71 | 83 | 101 | 117 | 84 | 63 | 82 | 84 | |
Minority Int. | |||||||||||
Equity & Liab. | 100 | 131 | 151 | 142 | 159 | 150 | 149 | 142 | 185 | 187 | |
Non Curr. Assets | 41 | 84 | 86 | 84 | 81 | 78 | 77 | 74 | 92 | 86 | |
Curr. Assets | 59 | 48 | 65 | 59 | 77 | 71 | 72 | 68 | 93 | 102 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 100 | 131 | 151 | 142 | 159 | 150 | 149 | 142 | 185 | 187 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 134 | 119 | 150 | 166 | 183 | 190 | 181 | 199 | 244 | 252 | |
Other Income | 0 | 1 | 3 | 0 | 2 | 2 | 1 | 0 | 1 | 1 | |
Total Income | 134 | 120 | 153 | 166 | 185 | 192 | 182 | 199 | 245 | 253 | |
Total Expenditure | -123 | -117 | -140 | -159 | -168 | -173 | -164 | -169 | -213 | -217 | |
PBIDT | 11 | 3 | 13 | 7 | 17 | 19 | 18 | 30 | 32 | 35 | |
Interest | -4 | -3 | -11 | -9 | -10 | -11 | -10 | -7 | -5 | -6 | |
Depreciation | -2 | -3 | -5 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | |
Taxation | -6 | 1 | 3 | 1 | 0 | -1 | -2 | -12 | -7 | ||
Exceptional Items | -2 | -1 | 18 | ||||||||
PAT | 0 | -3 | -1 | -7 | 1 | 0 | 1 | 14 | 27 | 16 | |
Adjusted EPS | -1 | -4 | -1 | -9 | 2 | 0 | 1 | 19 | 37 | 22 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 15 | -7 | 13 | 1 | 12 | 2 | 15 | 19 | 35 | 33 | |
Cash Fr. Inv. | -1 | -3 | -31 | -17 | -3 | -4 | -2 | -7 | -4 | -17 | |
Cash Fr. Finan. | -14 | 12 | 15 | 18 | -8 | 3 | -30 | -24 | -7 | -9 | |
Net Change | 0 | 2 | -3 | 2 | 1 | 1 | -18 | -11 | 23 | 7 | |
Cash & Cash Eqvt | 1 | 3 | 0 | 2 | 1 | 3 | -15 | -26 | -3 | 4 |
Mon, 23 Jan 2023
Board Meeting Intimation for Approval Of Results For The Quarter And Nine-Months Ended 31 December 2022 SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine-months ended 31st December 2022.Further in continuation of our intimation on closure of trading window on 28th December 2022 and pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives till 5th February 2023. |
Wed, 28 Dec 2022
Closure of Trading Window Notice is hereby given that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended the "Trading Window" (i.e. period to deal in the Companys shares) shall remain closed from 1st January 2023 till 48 hours after the unaudited financial results of the Company for the quarter and nine months ended 31st December 2022 are approved by the Board of Directors and filed with Stock Exchange.The date of proposed Board Meeting to approve unaudited financial results of the Company for the quarter and nine months ended 31st December 2022 will be informed in due course.Accordingly all Directors/Connected Persons/Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid period of closure of trading window. |
Fri, 23 Dec 2022
Announcement under Regulation 30 (LODR)-Resignation of Managing Director This is to inform you that Mr. Virendrasingh Baidwal (DIN- 05237385) Managing Director has submitted his resignation from the Board and its committees due to his health issues. His resignation as Managing Director is effective from 23rd December 2022. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and SEBI Circular CIR/CFD/CMD /4/20-15 dated September 9 2015 are given in the Annexure I.We request you to take the above disclosure on record. |
Mon, 30 Jan 2023 |
|
|
|
|
|